Free Trial
LON:GENI

GENinCode (GENI) Share Price, News & Analysis

GENinCode logo
GBX 1.54 -0.01 (-0.65%)
As of 11:19 AM Eastern

About GENinCode Stock (LON:GENI)

Key Stats

Today's Range
1.50
1.60
50-Day Range
1.43
3
52-Week Range
1
8.50
Volume
225,350 shs
Average Volume
729,078 shs
Market Capitalization
£2.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.

Receive GENI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GENinCode and its competitors with MarketBeat's FREE daily newsletter.

GENI Stock News Headlines

GENinCode (LON:GENI) Shares Up 3.1% - Should You Buy?
Shocking discovery could help you target payouts on weekends…
Since the pandemic, the average mortgage payment has jumped from $1,427 to $2,047. That's an extra $600 every single month just vanishing from people's pockets. Meanwhile, credit card debt is hitting record highs, and savings accounts are at their lowest since 2008. Most folks are left with two options… Get a second job... or work overtime on weekends. But what if there was a third option? I just uncovered a shocking anomaly in the options market that could change everything... One that lets you target extra cash on days when most people make nothing - weekends. Think what that could mean for your monthly budget...
See More Headlines

GENI Stock Analysis - Frequently Asked Questions

GENinCode's stock was trading at GBX 3.89 at the beginning of 2025. Since then, GENI shares have decreased by 60.4% and is now trading at GBX 1.54.
View the best growth stocks for 2025 here
.

Shares of GENI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that GENinCode investors own include QUALCOMM (QCOM), Sound Energy (SOU), Zura Bio (ZURA), Capital One Financial (COF), Lincoln National (LNC), Ovid Therapeutics (OVID) and Plug Power (PLUG).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
Entertainment
Current Symbol
LON:GENI
CIK
N/A
Fax
N/A
Employees
2,300
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£6.10 million
Net Margins
-228.70%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.67 million
Cash Flow
GBX 1.85 per share
Price / Cash Flow
0.83
Book Value
GBX 1.63 per share
Price / Book
0.95

Miscellaneous

Free Float
N/A
Market Cap
£2.73 million
Optionable
Not Optionable
Beta
0.66
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (LON:GENI) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners